Additionally, 24 variants were nominally associated with MYCN‐amplified neuroblastoma risk at P < .05, 23 of which were associated with adult height attainment and 1 of which was associated with childhood height attainment (Table S5), yet none were significantly associated with MYCN‐amplified neuroblastoma risk after Bonferroni correction. The gene discussed is MYCN; the disease is neuroblastoma.